Director, Thrombosis & Hemostasis Program
Undergraduate: Hacettepe University Faculty of Medicine, School of Basic Sciences
Graduate: Hacettepe University Faculty of Medicine, Ankara Turkey.
Residency: Hacettepe Medical Center, Hacettepe Children’s Hospital in Ankara, Turkey (1974-1978)
Fellowships: Immunology at Hacettepe Medical Center, Hacettepe Children’s Hospital Ankara Turkey (1977-1978)
Turkish Board of Pediatrics
American Board of Pediatrics
American Sub-Board of Pediatric Hematology-Oncology
Areas of Interest and Expertise
Childhood cancers including leukemia, lymphoma, neuroblastoma, solid tumors, brain tumors, histiocyctic disorders, platelet disorders, hemoglobinopathies, bleeding and thrombosis
- Sujith Sheth, Gerald Soff, Beau Mitchell, David Green, Shipra Kaicjer, Fernando Fireman, Oya Tugal, Ludovico Guarini, Patricia Giardina, and Louis Aledort. Managing incidentally diagnosed isolated factor VII deficiency perioperatively: a brief expert consensus report. Expert Review of Hematology. February 2012, Vol 5, No. 1. Pages 47-50.
- A. Valentino, C.E. Walsh, M.T. Reding, G.A.Young, O. Levendoglu-Tugal and D. L. Cooper. Haemophilia. (2012) 1-7. Patient and caregiver-reported bleeding symptoms and reasons for starting and stopping treatment with recombinant factor VIIa: analysis of the dosing observational study in haemophilia (DOSE).
- International Society and Pharmacoeconomics and Outcomes Reach. 15th Annual International Meeting. May 15-19, 2010 Hilton Atlanta, Atlanta, GA. Patient and Caregiver-reported symptoms and reasons for starting/stopping recombinant factor VIII treatment: Observations from the dosing observational study in hemophilia (DOSE). Abstract Code: PSY41.
- Rituximab therapy to prevent relapse in chronic relapsing thrombotic thrombocytopenic purpura (TTP) in a child. Jayabose S, Dunbar J, Nowicki TS, Tugal O, Ozkaynak MF, Sandoval C.Pediatr Hematol Oncol. 2011 Mar;28(2):167-72. doi: 10.3109/08880011003739414. Epub 2010 May 14